STAA
NASDAQ HealthcareSTAAR Surgical Company - Common Stock
Medical Instruments & Supplies
STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, and sells phakic implantable lenses for the eye and accessory delivery systems to deliver the lenses into the eye. The company offers implantable collamer lens product family (ICLs) comprising EVO ICL, EVO+ ICL, EVO Visian ICL, and EVO Viva ICL for use in refractive surgery for the treatment of visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia. It serves health care providers, including ophthalmic surgeons, vision and surgical centers, hospitals, government facilities, and distributors, as well as ophthalmologists. The company sells its products directly through its sales representatives in Japan, the United States, Germany, Spain, Singapore, Canada, and the United Kingdom, as well as through representatives and independent distributors in China, Korea, India, France, Benelux, Italy, and internationally. STAAR Surgical Company was incorporated in 1982 and is headquartered in Lake Forest, California.
๐ Market Data
| Price | $27.19 |
|---|---|
| Volume | 973,347 |
| Market Cap | 1.35B |
| Beta | 1.040 |
| RSI (14-Day) | 51.9 |
| 200-Day MA | $23.44 |
| 50-Day MA | $21.17 |
| 52-Week High | $30.81 |
| 52-Week Low | $15.59 |
| Forward P/E | 35.31 |
| Price / Book | 3.90 |
๐ฏ Investment Strategy Scores
STAA scores across each investment strategy. Higher is better for that strategy's goals.
๐ Strategy Interpretation
Best fit: ๐ Moon Shot (62/100) โ this strategy High growth potential (high beta + oversold).
Lowest fit among scored strategies: ๐ฐ Dividend Daddy (24/100). No single score is a buy or sell signal โ use multiple lenses together. Learn how to read these scores โ
๐ Learn More
Indicators on this page
Educational articles
Find STAA in your text
Paste any article, transcript, or post โ the tool will extract STAA and every other hidden ticker.
Disclaimer: This data is for educational and entertainment purposes only and does not constitute financial advice. Market data may be delayed. Always do your own research before making investment decisions.
Data last updated: 2026-05-01.